BioSpace News Archive

Press Releases

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

October 30, 2025
·
4 min read
Press Releases

PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025

October 30, 2025
·
3 min read
Press Releases

Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics

October 30, 2025
·
2 min read
Press Releases

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin

October 30, 2025
·
5 min read
Press Releases

PolarityBio Announces Acceptance of Category III CPT® Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT® Editorial Panel

October 30, 2025
·
2 min read
Press Releases

Johnson & Johnson announces first head-to-head study comparing IMAAVY™ with an alternative FcRn blocker in generalized myasthenia gravis (gMG) at AANEM Annual Meeting

October 30, 2025
·
20 min read
Press Releases

ENHERTU® approved in Canada as the first and only HER2-directed therapy for patients with HR-positive HER2-low or HER2-ultralow metastatic breast cancer, following disease progression after one or more endocrine therapies

October 30, 2025
·
9 min read
Press Releases

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

October 30, 2025
·
7 min read
Press Releases

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

October 30, 2025
·
1 min read
Press Releases

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo

October 30, 2025
·
18 min read